98
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximab

, , , , , , , & show all
Pages 155-160 | Received 23 Apr 2004, Accepted 28 Oct 2004, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shinya Hagiwara, Hiroto Tsuboi, Fumika Honda, Hidenori Takahashi, Izumi Kurata, Ayako Ohyama, Mizuki Yagishita, Saori Abe, Yuko Kurashima, Syunta Kaneko, Hoshimi Kawaguchi, Hiroyuki Takahashi, Hiroshi Ebe, Masahiro Yokosawa, Hiromitsu Asashima, Tomoya Hirota, Naoto Umeda, Yuya Kondo, Isao Matsumoto & Takayuki Sumida. (2016) Association of anti-Ro/SSA antibody with response to biologics in patients with rheumatoid arthritis. Modern Rheumatology 26:6, pages 857-862.
Read now
N Vuilleumier, J Bratt, R Alizadeh, T Jogestrand, I Hafström & J Frostegård. (2010) Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity. Scandinavian Journal of Rheumatology 39:6, pages 447-453.
Read now

Articles from other publishers (26)

Minjing Mao, Shuqin Xu, Lin Lin, Danfeng Dong, Minghui Xue, Siwei He & Gang Cai. (2022) Impact of Corticosteroids on the Proportions of Circulating Tfh Cell Subsets in Patients With Systemic Lupus Erythematous. Frontiers in Medicine 9.
Crossref
Anastasia Skalkou, Eleftherios Pelechas, Paraskevi V. Voulgari & Alexandros A. Drosos. (2022) TNF-induced Lupus. A Case-Based Review. Current Rheumatology Reviews 18:1, pages 72-82.
Crossref
Sofie Bliddal, Stina Willemoes Borresen & Ulla Feldt-Rasmussen. (2017) Thyroid Autoimmunity and Function after Treatment with Biological Antirheumatic Agents in Rheumatoid Arthritis. Frontiers in Endocrinology 8.
Crossref
Monica Salvi. (2016) Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis C. World Journal of Clinical Cases 4:2, pages 49.
Crossref
Ivica Lazúrová, Ivana Jochmanová, Karim Benhatchi & Štefan Sotak. (2014) Autoimmune thyroid disease and rheumatoid arthritis: relationship and the role of genetics. Immunologic Research 60:2-3, pages 193-200.
Crossref
HYOJU YI, JURYUN KIM, HYERIN JUNG, YERI ALICE RIM, YOUNGKYUN KIM, SEUNG MIN JUNG, SUNG-HWAN PARK & JI HYEON JU. (2014) Induced production of anti-etanercept antibody in collagen-induced arthritis. Molecular Medicine Reports 9:6, pages 2301-2308.
Crossref
João Luiz Pereira Vaz, Carlos Augusto Ferreira Andrade, Alessandra Cardoso Pereira, Maria de Fátima M. Martins & Roger Abramino Levy. (2013) Revisão sistemática da indução de autoanticorpos e lúpus eritematoso pelo infliximabe. Revista Brasileira de Reumatologia 53:4, pages 358-364.
Crossref
João Luiz Pereira Vaz, Carlos Augusto Ferreira Andrade, Alessandra Cardoso Pereira, Maria de Fátima M. Martins & Roger Abramino Levy. (2013) Systematic review of infliximab-induced autoantibodies and systemic lupus erythematosus. Revista Brasileira de Reumatologia (English Edition) 53:4, pages 358-364.
Crossref
Daiju Iwata, Kenichi Namba, Kazuomi Mizuuchi, Nobuyoshi Kitaichi, Satoru Kase, Yuko Takemoto, Shigeaki Ohno & Susumu Ishida. (2012) Correlation between elevation of serum antinuclear antibody titer and decreased therapeutic efficacy in the treatment of Behçet’s disease with infliximab. Graefe's Archive for Clinical and Experimental Ophthalmology 250:7, pages 1081-1087.
Crossref
RAN MATSUDAIRA, NAOTO TAMURA, FUMIO SEKIYA, MICHIHIRO OGASAWARA, KENJIRO YAMANAKA & YOSHINARI TAKASAKI. (2011) Anti-Ro/SSA Antibodies Are an Independent Factor Associated with an Insufficient Response to Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis. The Journal of Rheumatology 38:11, pages 2346-2354.
Crossref
Christopher Chang & M. Eric Gershwin. (2011) Drug-Induced Lupus Erythematosus. Drug Safety 34:5, pages 357-374.
Crossref
Anne-Barbara Mongey & Evelyn V. Hess. 2011. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 599 627 .
Christopher Chang & M. Eric Gershwin. (2010) Drugs and autoimmunity – A contemporary review and mechanistic approach. Journal of Autoimmunity 34:3, pages J266-J275.
Crossref
A.E. Pink, A. Fonia, M.H. Allen, C.H. Smith & J.N.W.N. Barker. (2009) Antinuclear antibodies associate with loss of response to antitumour necrosis factor-α therapy in psoriasis: a retrospective, observational study. British Journal of Dermatology 162:4, pages 780-785.
Crossref
Nádia Emi Aikawa, Jozélio Freire de Carvalho, Clovis Artur Almeida Silva & Eloísa Bonfá. (2009) Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases. Clinical Reviews in Allergy & Immunology 38:2-3, pages 82-89.
Crossref
Geneviève Servais, Rafik Karmali, Marie Paule Guillaume, Valérie Badot, Jean Duchateau & Francis Corazza. (2009) Anti DNA antibodies are not restricted to a specific pattern of fluorescence on HEp2 cells. Clinical Chemistry and Laboratory Medicine 47:5.
Crossref
Davyd R. Hooper, Mark A. Tarnopolsky & Steven K. Baker. (2008) Lewis–Sumner syndrome associated with infliximab therapy in rheumatoid arthritis. Muscle & Nerve 38:4, pages 1318-1325.
Crossref
A. Vultaggio, A. Matucci, P. Parronchi, O. Rossi, F. Palandri, S. Romagnani & E. Maggi. (2008) Safety and Tolerability of Infliximab Therapy: Suggestions and Criticisms Based on Wide Clinical Experience. International Journal of Immunopathology and Pharmacology 21:2, pages 367-374.
Crossref
Anne-Barbara Mongey & Evelyn V Hess. (2008) Drug Insight: autoimmune effects of medications—what's new?. Nature Clinical Practice Rheumatology 4:3, pages 136-144.
Crossref
Mark Lebwohl, Jerry Bagel, Joel M. Gelfand, Dafna Gladman, Kenneth B. Gordon, Sylvia Hsu, Robert E. Kalb, Alexa Boer Kimball, Neil J. Korman, Gerald G. Krueger, Philip Mease, Warwick L. Morison, Amy Paller, David M. Pariser, Christopher Ritchlin, Bruce Strober, Abby Van Voorhees, Gerald D. Weinstein, Melodie Young & Liz Horn. (2008) From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis. Journal of the American Academy of Dermatology 58:1, pages 94-105.
Crossref
Manuel Ramos-Casals, Pilar Brito-Zerón, Sandra Muñoz, Natalia Soria, Diana Galiana, Laura Bertolaccini, Maria-Jose Cuadrado & Munther A. Khamashta. (2007) Autoimmune Diseases Induced by TNF-Targeted Therapies. Medicine 86:4, pages 242-251.
Crossref
Y. Sherer, R. Gerli, B. Gilburd, E. Bartoloni Bocci, G. Vaudo, E. Mannarino & Y. Shoenfeld. (2016) Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies. Lupus 16:4, pages 259-264.
Crossref
Richard G. Langley, Edward C. Keystone, Robert Bissonnette & Kim A. Papp. (2016) Long-Term Safety of Etanercept. Journal of Cutaneous Medicine and Surgery 11:2_suppl, pages S23-S36.
Crossref
Alexander P. Rozin. (2006) From molecular mimicry to cross-reactivity or pathogen expansion? A hypothesis. Clinical Rheumatology 26:3, pages 285-288.
Crossref
N. Poulalhon, E. Begon, C. Lebbé, F. Lioté, M. Lahfa, D. Bengoufa, P. Morel, L. Dubertret & H. Bachelez. (2007) A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity. British Journal of Dermatology 156:2, pages 329-336.
Crossref
Michelle T. Pelle. (2006) Issues and Advances in the Management and Pathogenesis of Cutaneous Lupus Erythematosus. Advances in Dermatology 22, pages 55-65.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.